Breaking News, Promotions & Moves

Bellicum Pharmaceuticals Appoints New CMO

William Grossman has a history in development of cancer immunotherapies and combinations

Bellicum Pharmaceuticals has appointed William Grossman, M.D., Ph.D., as chief medical officer, effective February 5. Dr. Grossman joins Bellicum from Genentech/Roche.   “We are excited to have Bill join Bellicum. His expertise in the development of cancer immunotherapies and combinations will strengthen our team as we advance and expand our CAR T and TCR pipeline and prepare for the regulatory filing and potential commercialization of BPX-501 in Europe,” said Bellicum’s president & ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters